Contact
Please use this form to send email to PR contact of this press release:
Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of February 3, 2023 Lead Plaintiff Deadline
TO: